Literature DB >> 3534565

Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi.

M J Alves, G Abuin, V Y Kuwajima, W Colli.   

Abstract

Monoclonal antibodies were raised against the surface of trypomastigote forms of Trypanosoma cruzi. Although some of these antibodies reacted against antigens shared by trypomastigote and epimastigote or amastigote forms, the majority were trypomastigote-specific. Trypomastigote-specific monoclonal antibodies recognized all infective stages, including trypomastigotes from the bloodstream of infected mice, insect feces, tissue culture and those resulting from differentiation of epimastigotes in axenic culture media. The monoclonal antibodies H1A10 and 6A2, as well as Fab fragments from H1A10, partially prevented T. cruzi invasion of LLC-MK2 cell monolayers (inhibition of 50-70%) when present throughout the entire experiment. Both antibodies recognized an 85 kDa glycoprotein (Tc-85) of the trypomastigote surface which contains N-acetyl-D-glucosamine and/or sialic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534565     DOI: 10.1016/0166-6851(86)90081-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  32 in total

1.  Characterization of the cell adhesion site of Trypanosoma cruzi metacyclic stage surface glycoprotein gp82.

Authors:  P M Manque; D Eichinger; M A Juliano; L Juliano; J E Araya; N Yoshida
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and assessment of antigen stability for the three assays.

Authors:  Mariolga Berrizbietia; Momar Ndao; Marcelo Gottschalk; Alberto Aché; Fabio Vásquez; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein.

Authors:  S J Kahn; M Wleklinski; R A Ezekowitz; D Coder; A Aruffo; A Farr
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi.

Authors:  N Yoshida; R A Mortara; M F Araguth; J C Gonzalez; M Russo
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  A method of identifying and isolating a unique member of a multigene family: application to a trypanosome surface antigen gene.

Authors:  B J Ruef; J H Hecht; J E Manning
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

6.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms.

Authors:  L E Bertello; M F Gonçalvez; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.

Authors:  S Kahn; M Wleklinski; A Aruffo; A Farr; D Coder; M Kahn
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  Alterations in the surface charge of heart muscle cells during interaction with Trypanosoma cruzi.

Authors:  M de N Soeiro; F Costa e Silva Filho; M de N Leal de Meirelles
Journal:  Cell Biophys       Date:  1995-02

10.  Characterization of a cDNA clone encoding the carboxy-terminal domain of a 90-kilodalton surface antigen of Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  F R Franco; G S Paranhos-Bacallà; L M Yamauchi; N Yoshida; J F da Silveira
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.